Walder Wyss advised CorFlow Therapeutics AG on the deal. Kellerhals Carrard advised Broadview Ventures and Panakes Partners. CorFlow Therapeutics AG completed a series B financing round...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised European media group Mediahuis on the financing. Mediahuis Marketplaces and CareerFairy completed a growth financing round. European media group Mediahuis, which acted as lead-investor,...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised Mediahuis on the financing. CareerFairy successfully concluded a growth financing round. European media group Mediahuis Marketplaces acted as the lead investor. This financing round...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advises Q-SYS in this transaction. Q-SYS, a division of US-based QSC LLC, has announced a definitive agreement to acquire Seervision, a Swiss-based industry...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Unilabs in this transaction. Wenger Vieli advised the shareholders of RIMED. Unilabs, a leading diagnostic services provider, and RIMED, a leading Swiss...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Gyrus Capital in this transaction, alongside with Chiomenti (Italian law) and Wolf Theiss (Albanian law). Consulcesi and Falcon Industrial was advised by...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Heubach and SK Capital on this transaction. Homburger advised Clariant. Kirkland & Ellis advised SK Capital Partners on the deal. The Heubach...
You must be a Standard 1 Year member to access this content.
